4th NASH Roundtable™ Virtual Forum

The 4th NASH Roundtable™ Virtual Forum was held on November 18, 2021, with presentations and a Roundtable Member discussion focused on opportunities for collaboration bridging expertise from pharma, biotech, clinical research, and academic research.

Forum Co-Chairs and Moderators


Arun J. Sanyal, MD

Z. Reno Vlahcevic Professor of Medicine at Virginia Commonwealth University School of Medicine


Rohit Loomba, MD

Professor of Medicine, Director of Hepatology, at University of California at San Diego and Founding Director of the UCSD NAFLD Research Center


Marcus Hompesch, MD

President & CEO, ProSciento, Inc. and Editor-in-Chief, Endocrinology, Diabetes & Metabolism

Keynote Presenters

Julio Gutierrez, MD Vice President of Clinical Research and Clinical Science, ProSciento, Inc., and Transplant Hepatologist at Scripps Health

Morten Karsdal, PhD Chief Executive Officer, Nordic Bioscience A/S

Lars Johansson, PhD Chief Scientific Officer, Antaros Medical AB

Arun J. Sanyal, MD Professor, Division of Gastroenterology, Hepatology and Nutrition, at Virginia Commonwealth University School of Medicine

About the NASH Roundtable™

The NASH Roundtable™ was established in 2018 as a platform to stimulate collaboration and build consensus towards validated biomarkers and endpoints and to support the development of effective and safe treatments. Today the Roundtable consists of distinguished physicians, researchers, and clinical development experts from three continents brought together by their common commitment to steward advances in science, clinical research, and therapeutics for fibrotic diseases.